Registration number (WIID)Project No.TitleStatus
9472LVS EN 30993-5:1994Biological evaluation of medical devices - Part 5: Tests for cytotoxicity - in vitro methods (ISO 10993-5:1992)Atcelts
31982LVS EN ISO 10993-10:2009Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity (ISO 10993-10:2002, including Amd 1:2006)Atcelts
77933prEN ISO 10993-11Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2025)Aptauja
78988prEN ISO 10993-3Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity (ISO/DIS 10993-3:2025)Aptauja
78994EN ISO 10993-17:2023/prA1Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/DAmd 1:2024)Aptauja slēgta
77939EN ISO 10993-4:2017/A1:2025Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood - Amendment 1 (ISO 10993-4:2017/Amd 1:2025, Corrected version 2025-04)Standarts spēkā
60723EN ISO 10993-15:2023Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys (ISO 10993-15:2019)Standarts spēkā
60725EN ISO 10993-18:2020Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)Standarts spēkā
60721LVS EN ISO 10993-1:2021Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11)Standarts spēkā
60722LVS EN ISO 10993-9:2021Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)Standarts spēkā
Displaying 131-140 of 190 results.